On June 17, 2026, Knight Therapeutics Inc. (TSX: GUD), a pharmaceutical company operating in the Americas excluding the United States, disclosed that it has fully settled the debt under its revolving credit facility with National Bank of Canada and several lenders. The repayment marks a significant milestone in the company's financial operations.